Spire Wealth Management Trims Veeva Systems Stake

Institutional investor reduces holding in cloud software company by nearly 98%

Apr. 4, 2026 at 9:12am

A highly detailed, cinematic close-up of the heavy, industrial components that make up the inner workings of a bank vault, conveying a sense of the tangible infrastructure and institutional power underlying the digital economy.An extreme close-up of the complex mechanical systems that secure a financial institution's assets reflects the institutional nature of Veeva Systems' cloud software solutions.Pleasanton Today

Spire Wealth Management, an institutional investor, has reduced its stake in Veeva Systems Inc. (NYSE: VEEV) by 97.9% during the fourth quarter, according to a recent 13F filing. The firm now owns just 448 shares of the technology company's stock, down from a previous holding of 20,964 shares.

Why it matters

Veeva Systems is a leading provider of cloud-based software solutions for the global life sciences industry. The company's significant institutional ownership and trading activity can provide insights into market sentiment and potential shifts in the stock's performance.

The details

According to the 13F filing, Spire Wealth Management sold 20,516 shares of Veeva Systems during the fourth quarter, reducing its total position to just 448 shares. The firm's holdings in Veeva were valued at $100,000 at the end of the reporting period.

  • Spire Wealth Management reduced its Veeva Systems stake during the fourth quarter of 2026.

The players

Spire Wealth Management

An institutional investor that has reduced its holdings in Veeva Systems by nearly 98%.

Veeva Systems Inc.

A cloud software company that develops industry-specific applications and data solutions for the global life sciences sector.

Got photos? Submit your photos here. ›

The takeaway

The significant reduction in Spire Wealth Management's Veeva Systems position could signal a shift in institutional sentiment towards the stock, though more data would be needed to draw definitive conclusions. Investors will likely continue to monitor trading activity and analyst commentary around Veeva Systems as it navigates the evolving life sciences software market.